Biogen Inc Dividends
The next dividend date for Biogen Inc has not yet been scheduled.
What is a Dividend Date
When we talk about a dividend date, we’re referring specifically to the ex-dividend date.
This is the date on which all stockholders will earn a dividend. Technically, a person needs to be the owner of a share of stock as of the night before the ex-dividend date in order to earn the dividend.
The ex-dividend date is different than the date when the dividend is issued. Although you earn a dividend on the ex-dividend date, that dividend is typically not disbursed to your account until several weeks later.
Most brokerages will automatically credit the dividend to your account once it’s issued.
Historical Dividends for Biogen Inc (BIIB)
| No results. | ||||
More About Biogen Inc
Biogen Inc. discovers, develops, manufactures, and delivers therapies in the United States, Europe, Germany, Asia, and internationally. The company provides TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, and TYSABRI for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; SKYCLARYS to treat Friedreich's Ataxia; QALSODY for treating amyotrophic lateral sclerosis; FUMADERM to treat plaque psoriasis; BENEPALI, an etanercept biosimilar referencing ENBREL; IMRALDI, an adalimumab biosimilar referencing HUMIRA; FLIXABI, an infliximab biosimilar referencing REMICADE. It offers LEQEMBI for the treatment of Alzheimer's disease; ZURZUVAE for the treatment of postpartum depression; RITUXAN to treat non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid arthritis, two forms of ANCA-associated vasculitis, and pemphigus vulgaris; RITUXAN HYCELA for non-Hodgkin's lymphoma and CLL; GAZYVA to treat CLL and follicular lymphoma; OCREVUS for relapsing MS and primary progressive MS; LUNSUMIO to treat relapsed or refractory follicular lymphoma; glofitamab for aRelapsed or refractory diffuse large B-cell lymphoma; and other anti-CD20 therapies. Biogen Inc. has collaboration and license agreements with Merz Therapeutics; Alkermes Pharma Ireland Limited; Denali Therapeutics Inc.; UCB; Eisai Co., Ltd.; Genentech, Inc.; Neurimmune SubOne AG; Ionis Pharmaceuticals, Inc.; Samsung Bioepis; and Sage Therapeutics, Inc., as well as collaborations with Stoke Therapeutics, Inc. for the development and commercialization of zorevunersen, a disease modifying medicine for the treatment of Dravet syndrome; Dayra Therapeutics, Inc. to develop oral macrocyclic peptides; Vanqua Bio, Inc. for developing Vanqua's preclinical oral C5aR1 antagonist compound; City Therapeutics, Inc. to develop select novel RNAi therapies; and ALTEOGEN Inc. to develop subcutaneous (SC) formulations of biologics utilizing ALT-B4. The company was founded in 1978 and is headquartered in Cambridge, Massachusetts.
Owning Biogen Inc Stock on the Dividend Date
If you own Biogen Inc stock on the ex-dividend date, then you earn the associated dividend.
Theoretically, the price of Biogen Inc stock should go down by the amount of the dividend (in addition to any other pressures that market forces have on the price of Biogen Inc stock).
Therefore, it is typically not expected that there is any incremental profit to be gained from buying Biogen Inc stock right before the ex-dividend date and then selling it immediately after. It’s not like you get the Biogen Inc dividend payout for free just by doing that since there is typically an equivalent commensurate drop in the stock price.
Owning Biogen Inc Options on the Dividend Date
Unlike the stock price, which will normally have an abrupt decrease by the amount of the dividend on the ex-dividend date, option prices typically do not reflect the same phenomenon.
The reason is that in the time leading up to the ex-dividend date, that projected drop in Biogen Inc stock price from the dividend is already baked into Biogen Inc option prices.
That means the prices of call options that overlap the Biogen Inc ex-dividend date typically go down in the period leading up to the ex-dividend date.
The prices of put options that overlap the Biogen Inc ex-dividend date typically go up in the period leading up to the ex-dividend date.
Owners of Biogen Inc call options do not receive the dividend, even if they own the options on the ex-dividend date. Owners of Biogen Inc put options are not responsible to pay the dividend, even if they own the options on the ex-dividend date.
Learning More Biogen Inc Dividends
You can contact us any time if you would like to ask questions about Biogen Inc dividends or anything else related to the stock market.